Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
20.8M
-
Number of holders
-
130
-
Total 13F shares, excl. options
-
95.1M
-
Shares change
-
+1.15M
-
Total reported value, excl. options
-
$938M
-
Value change
-
+$10.3M
-
Put/Call ratio
-
3.64
-
Number of buys
-
49
-
Number of sells
-
-76
-
Price
-
$9.86
Significant Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q1 2021
165 filings reported holding ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share as of Q1 2021.
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) has 130 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 95.1M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (9.37M shares), Avoro Capital Advisors LLC (8M shares), RTW INVESTMENTS, LP (7.35M shares), BlackRock Inc. (7.22M shares), Sonic Fund II, L.P. (6.55M shares), ORBIMED ADVISORS LLC (5.5M shares), STATE STREET CORP (5.27M shares), Versant Venture Management, LLC (5.07M shares), VANGUARD GROUP INC (4.58M shares), and UBS Group AG (3.3M shares).
This table shows the top 130 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.